Antibiotics (AB) is a drug that was instrumental in the fight against infections caused by bacteria. Although the use of a good AB applies to all ages, AB for pediatric populations need special attention because of the tendency of excessive usage. Pediatric clinic pediatric patients who met with almost every 1-3 weeks to come back - mostly - with the same complaints, including fever, cough and runny nose. This is a phenomenon that does not happen in Western countries. Young children, especially infants, need a healthy growth with no AB when there is no certainty of bacterial infection.
That more concern is that the population of children is an age group that has no data on its use, because they do not / rarely performed as clinical trials of adults. Dose of medicine, was not performed dose-ranging studies (dose determination study) is quite complex. Although there are no regulations that do not allow research on children around the world, permitting the drug in children are rarely given exclusively by the FDA (Food and Drug Administration) United States, and strangely not requested by the FDA as a condition of permission marketing. This is true all over the world, as if there are barriers to conducting a study in children. Specialized in Japanese women are also not allowed (forbidden) is used as a clinical trial subjects. This raises the absence of human data on both types of drug use. In the case of parents also requested data by the FDA when needed, because they are specialized to react other than the younger population.
That more concern is that the population of children is an age group that has no data on its use, because they do not / rarely performed as clinical trials of adults. Dose of medicine, was not performed dose-ranging studies (dose determination study) is quite complex. Although there are no regulations that do not allow research on children around the world, permitting the drug in children are rarely given exclusively by the FDA (Food and Drug Administration) United States, and strangely not requested by the FDA as a condition of permission marketing. This is true all over the world, as if there are barriers to conducting a study in children. Specialized in Japanese women are also not allowed (forbidden) is used as a clinical trial subjects. This raises the absence of human data on both types of drug use. In the case of parents also requested data by the FDA when needed, because they are specialized to react other than the younger population.
0 comments:
Post a Comment